Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation

Leukemia

Volumn 25, Issue 3, 2011, Pages 449-454

  Madureira, A B M ^a   Eapen, M ^b   Locatelli, F ^c,d   Teira, P ^a   Zhang, M J ^b   Davies, S M ^e   Picardi, A ^f   Woolfrey, A ^g   Chan, K W ^h   Socie G ^a   Vora, A ⁱ   Bertrand, Y ^j   Sales Bonfim, C M ^k   Gluckman, E ^a   Niemeyer, C ^l   Rocha, V ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g Fred Hutchinson Cancer Research Center   (United States)

^h TEXAS TRANSPLANT INSTITUTE   (United States)

ⁱ SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^j HÔPITAL DEBROUSSE   (France)

^k FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^l UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

childhood; cord blood transplantation; monosomy 7; myelodysplastic syndrome

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHOTREXATE; STEROID; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; DEATH; DISEASE FREE SURVIVAL; DONOR; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; IRRADIATION; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; RECURRENT DISEASE; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; RISK FACTOR; SIBLING; TREATMENT FAILURE;

EID: 79952445223     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.285     Document Type: Article

References (37)

1. Locatelli F, Zecca M, Pession A, Maserati E, De Stefano P, Severi F. Myelodysplastic syndromes: the pediatric point of view. Haematologica 1995; 80: 268-279. .
2. Kardos G, Baumann I, Passmore SJ, Locatelli F, Hasle H, Schultz KR et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 2003; 102: 1997-2003. . (Pubitemid 37122372)
3. Hasle H, Baumann I, Bergstrasser E, Fenu S, Fischer A, Kardos G et al. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML). Leukemia 2004; 18: 2008-2014. . (Pubitemid 40028428)
4. Creutzig U, Bender-Gotze C, Ritter J, Zimmermann M, Stollmann- Gibbels B, Korholz D et al. The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t. Leukemia 1998; 12: 652-659. . (Pubitemid 28220816)
5. Guinan EC, Tarbell NJ, Tantravahi R, Weinstein HJ. Bone marrow transplantation for children with myelodysplastic syndromes. Blood 1989; 73: 619-622. . (Pubitemid 19060553)
6. Hasle H, Kerndrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N et al. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 1996; 10: 1269-1273. . (Pubitemid 26261421)
7. Locatelli F, Pession A, Bonetti F, Maserati E, Prete L, Pedrazzoli P et al. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia 1994; 8: 844-849. . (Pubitemid 24161092)
8. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-2971. .
9. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947-1954. . (Pubitemid 46874578)
10. Picardi A, Del Principe D, Cudillo L, Dentamaro T, Amadori S, de Fabritiis P. Unrelated cord blood transplantation for children with high risk myelodysplastic syndromes. Haematologica 2004; 89: ELT08. .
11. Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003; 17: 277-282. . (Pubitemid 36266902)
12. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304. .
13. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A longterm clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217. . (Pubitemid 10036817)
14. Fine JP, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509. .
15. Kaplan E. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481. .
16. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187. .
17. Hasle H. Myelodysplastic and myeloproliferative disorders in children. Curr Opin Pediatr 2007; 19: 1-8. . (Pubitemid 46114751)
18. Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 2003; 102: 4290-4297. . (Pubitemid 37494086)
19. Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999; 93: 3662-3671. . (Pubitemid 29249812)
20. Rocha V, Michel G, Kabbara N, Arcese W, Ortega J, Iori AP et al. Outcomes after unrelated cord blood transplantation in children with acute lymphoblastic leukemia: a Eurocord-Netcord survey (abstr# 304). Blood 2005; 106: 93a. .
21. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343-1347. . (Pubitemid 40170912)
22. Locatelli F, Zecca M, Niemeyer C, Angelucci E, Arcese G, Bender-Gotze C et al. Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria- Germany-Italy (AGI) Bone Marrow Transplantation Registry. Bone Marrow Transplant 1996; 18 (Suppl 2): 63-68. .
23. Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant 2004; 33: 805-814. . (Pubitemid 38519241)
24. Davies SM, Wagner JE, Defor T, Blazar BR, Katsanis E, Kersey JH et al. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia. Br J Haematol 1997; 96: 749-756. . (Pubitemid 27115871)
25. Webb DK, Passmore SJ, Hann IM, Harrison G, Wheatley K, Chessells JM. Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99. Br J Haematol 2002; 117: 33-39. . (Pubitemid 34304418)
26. de Witte T, Pikkemaat F, Hermans J, van Biezen A, Mackinnan S, Cornelissen J et al. Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation. Leukemia 2001; 15: 1878-1884. . (Pubitemid 33114994)
27. Anderson JE, Appelbaum FR, Fisher LD, Schoch G, Shulman H, Anasetti C et al. Allogeneic bone marrow transplantation for patients with myelodysplastic syndrome. Blood 1993; 82: 677-681. . (Pubitemid 23206138)
28. Hasle H, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U et al. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). Leukemia 1999; 13: 376-385. . (Pubitemid 29108076)
29. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397-407. . (Pubitemid 38410917)
30. Borojevic R, Roela RA, Rodarte RS, Thiago LS, Pasini FS, Conti FM et al. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression. Leuk Res 2004; 28: 831-844. . (Pubitemid 38760045)
31. Aizawa S, Nakano M, Iwase O, Yaguchi M, Hiramoto M, Hoshi H et al. Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro. Leuk Res 1999; 23: 239-246. . (Pubitemid 29083379)
32. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/ umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717-2722. .
33. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618. . (Pubitemid 34925136)
34. Parikh SH, Mendizabal A, Martin PL, Prasad VK, Szabolcs P, Driscoll TA et al. Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a singlecenter experience. Biol Blood Marrow Transplant 2009; 15: 948-955. .
35. Trobaugh-Lotrario AD, Kletzel M, Quinones RR, McGavran L, Proytcheva MA, Hunger SP et al. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT). Bone Marrow Transplant 2005; 35: 143-149. . (Pubitemid 40185929)
36. Strahm B, Locatelli F, Bader P, Ehlert K, Kremens B, Zintl F et al. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplant 2007; 40: 329-333. . (Pubitemid 47202417)
37. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007; 110: 3064-3070. (Pubitemid 350006962)